Ectopic expression of BBS1 rescues male infertility, but not retinal degeneration, in a BBS1 mouse model

Matthew R. Cring,Kacie J. Meyer,Charles C. Searby,Adam Hedberg-Buenz,Michael Cave,Michael G. Anderson,Kai Wang,Val C. Sheffield
DOI: https://doi.org/10.1038/s41434-021-00241-1
2021-03-04
Gene Therapy
Abstract:Bardet–Biedl syndrome (BBS) is a rare ciliopathy for which there are no current effective treatments. BBS is a genetically heterogeneous disease, though the M390R mutation in <i>BBS1</i> is involved in ~25% of all genetic diagnoses of BBS. The principle features of BBS include retinal degeneration, obesity, male infertility, polydactyly, intellectual disability, and renal abnormalities. Patients with mutations in BBS genes often present with night blindness within the first decade of life, which progresses to complete blindness. This is due to progressive loss of photoreceptor cells. Male infertility is caused by a lack of spermatozoa flagella, rendering them immobile. In this study, we have crossed the wild-type human <i>BBS1</i> gene, driven by the CAG promoter, onto the <i>Bbs1</i><sup><i>M390R/M390R</i></sup> mouse model to determine if ectopic expression of <i>BBS1</i> rescues male infertility and retinal degeneration. qRT-PCR indicates that the <i>BBS1</i> transgene is expressed in multiple tissues throughout the mouse, with the highest expression seen in the testes, and much lower expression in the eye and hypothalamus. Immunohistochemistry of the transgene in the eye showed little if any expression in the photoreceptor outer nuclear layer. When male <i>Bbs1</i><sup><i>M30R/M390R</i></sup><i>;BBS1</i><sup><i>TG+</i></sup> mice are housed with WT females, they are able to sire offspring, indicating that the male infertility phenotype of BBS is rescued by the transgene. Using electroretinography (ERGs) to measure retinal function and optical coherence tomography to measure retinal thickness, we show that the transgene does not confer protection against retinal degeneration in <i>Bbs1</i><sup><i>M300R/M390R</i></sup><i>;BBS1</i><sup><i>TG+</i></sup> mice. The results of this study indicate that the male infertility aspect of BBS is an attractive target for gene therapy.
genetics & heredity,biochemistry & molecular biology,medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?